ODRIK 4 mg, hard capsule 90 capsules
Active ingredients: Trandolapril
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Hard capsule90 capsulesorale
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- ODRIK 4 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC PVDC aluminium de 90 gélule(s)
- Marketing authorisation holder
- VIATRIS MEDICAL
- Reimbursement according to BDPM
- 65%
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans le cas suivant :<br><br>- Hypertension artérielle ; JOURNAL OFFICIEL ; 11/08/06
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 23 Aug 2018
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62481448CIP73713752CIP133400937137522Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TRANDOLAPRILgélule | 4 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.